2021 Tennessee Code
Part 5 - Genetic Testing
§ 68-5-507. Screening Program for Critical Cyanotic Congenital Heart Disease for Newborns

On or before January 1, 2013, the genetic advisory committee is directed to develop a screening program for critical cyanotic congenital heart disease for the panel of screens authorized for newborns under § 68-5-504 that makes use of pulse oximetry.